Cowen analyst Chris Shibutani reiterated an Outperform rating on Viela Bio (NASDAQ: VIE) and raised its DCF-based valuation target from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE